Clinical Trial Update: A Study of LY4064912 in Healthy Participants and With Overweight or Obesity [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating LY4064912 in healthy participants and in individuals with overweight or obesity; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY4064912

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight or Obesity, Healthy | Phase 1 | Status: RECRUITING